Key factors underlying the willingness of patients with cancer to participate in medication redispensing

被引:12
作者
Smale, E. M. [1 ]
Egberts, T. C. G. [2 ,3 ]
Heerdink, E. R. [2 ,3 ,4 ]
van den Bemt, B. J. F. [1 ,5 ]
Bekker, C. L. [1 ]
机构
[1] Radboud Univ Nijmegen, Radboud Inst Hlth Sci, Dept Pharm, Med Ctr, POB 9101, NL-6500 HB Nijmegen, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Pharm, Div Lab Pharm & Genet, POB 85500, NL-3508 GA Utrecht, Netherlands
[3] Univ Utrecht, Fac Sci, Utrecht Inst Pharmaceut Sci UIPS, Div Pharmacoepidemiol & Clin Pharmacol, POB 80082, NL-3508 TB Utrecht, Netherlands
[4] Utrecht Univ Appl Med Ctr Utrecht, Res Grp Innovat Pharmaceut Care, POB 85500, NL-3508 GA Utrecht, Netherlands
[5] Sint Maartensklin, Dept Pharm, POB 9011, NL-6500 GM Nijmegen, Netherlands
关键词
Medication waste; Medication redispensing; Medicine reuse; Oncology; Qualitative research; COM-B model; ADJUVANT HORMONAL-THERAPY; MEDICINES; ADHERENCE; WASTE;
D O I
10.1016/j.sapharm.2021.12.004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Redispensing medication unused by patients to other patients could reduce the environmental burden of medication waste. Simultaneously, associated financial loss could be reduced, particularly for expensive medication such as oral anticancer drugs. An important determinant for successful medication redispensing is patient participation.Objective(s): To identify key factors underlying the willingness of patients with cancer to participate in the redispensing of unused oral anticancer drugs.Methods: Semi-structured interviews via telephone or video call were conducted with adult patients diagnosed with cancer from two Dutch hospitals. The interview guide was framed using the COM-B model for behavioural change, to elicit patients' capability, opportunity and motivation to participate in medication redispensing. Questions were related to patients' willingness to accept redispensed medication, reasons thereof, perceived concerns and needs. Inductive thematic analysis was applied.Results: Seventeen patients (aged 38-82 years, 71% female), with nine different types of cancer participated. The majority of participants supported medication redispensing. Four categories of key factors underlying the willingness of patients with cancer to participate in medication redispensing were identified. First, the driver for participation was having positive societal impact, relating to affordability and sustainability of healthcare. Second, having trust in product quality was a requirement, influenced by preconceived beliefs, quality assurance and patients' knowledge of this process. Third, a facilitator for participating in medication redispensing was adequate provision of information. This concerned awareness of medication waste, information about medication redispensing, support from healthcare providers and other patients, and insight into medication dispensing history. Last, a convenient process for returning unused medication to pharmacies would facilitate participation in medication redispensing.Conclusions: The willingness of patients with cancer to participate in medication redispensing relates to a drive for achieving positive societal impact, provided that medication is of high quality, there is adequate information provision and a convenient process.
引用
收藏
页码:3329 / 3337
页数:9
相关论文
共 53 条
[1]  
Alhamad H, 2018, INT J PHARM PRACT, V26, P12
[2]   How do people conceptualise the reuse of medicines? An interview study [J].
Alhamad, Hamza ;
Patel, Nilesh ;
Donyai, Parastou .
INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2018, 26 (03) :232-241
[3]   Can We Create a Circular Pharmaceutical Supply Chain (CPSC) to Reduce Medicines Waste? [J].
Alshemari, Abdullah ;
Breen, Liz ;
Quinn, Gemma ;
Sivarajah, Uthayasankar .
PHARMACY, 2020, 8 (04) :1-22
[4]   Medication adherence among adults prescribed imatinib, dasatinib, or nilotinib for the treatment of chronic myeloid leukemia [J].
Anderson, Kristin R. ;
Chambers, Carole R. ;
Lam, Nadine ;
Yau, Patrick S. ;
Cusano, Frances ;
Savoie, M. Lynn ;
Sheikh, Naureen .
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2015, 21 (01) :19-25
[5]  
[Anonymous], 2011, Case before the Court of Justice of the European Union-Kingdom of Spain v Council of the European Union
[6]  
[Anonymous], 2018, STATE WORLD FISHERIE, P210
[7]  
[Anonymous], 2021, Trial NL 9208
[8]   Quantity and economic value of unused oral anti-cancer and biological disease-modifying anti-rheumatic drugs among outpatient pharmacy patients who discontinue therapy [J].
Bekker, C. L. ;
Melis, E. J. ;
Egberts, A. C. G. ;
Bouvy, M. L. ;
Gardarsdottir, H. ;
van den Bemt, B. J. F. .
RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2019, 15 (01) :100-105
[9]   Willingness of patients to use unused medication returned to the pharmacy by another patient: a cross-sectional survey [J].
Bekker, Charlotte ;
van den Bemt, Bart ;
Egberts, Toine C. G. ;
Bouvy, Marcel ;
Gardarsdottir, Helga .
BMJ OPEN, 2019, 9 (05)
[10]   What does it cost to redispense unused medications in the pharmacy? A micro-costing study [J].
Bekker, Charlotte L. ;
Gardarsdottir, Helga ;
Egberts, Antoine C. G. ;
Molenaar, Hendrik A. ;
Bouvy, Marcel L. ;
van den Bemt, Bart J. F. ;
Hovels, Anke M. .
BMC HEALTH SERVICES RESEARCH, 2019, 19 (1)